Callie Lesher
Adult Health · Leesburg, VANPI 1700332616
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,802 of the $3,279 with a category attached, or 85.5%. It is spread thinly across 39 manufacturers, the largest accounting for just 21.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,201 and has fallen 98.2% since, to $22 in 2025.
Across 134 payments — averaging $24.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$714
- Seagen Inc.$360
- Pharmacyclics LLC, An Abbvie Company$265
- Pfizer$220
- AbbVie$149
- Daiichi Sankyo Inc.$140
- plus $1K from 33 others
What the payments were for
- Food & beverage$2,80285%
- Education$47715%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson(2 entities) | 28 | $714 |
| Seagen Inc. | 10 | $360 |
| Pharmacyclics LLC, An Abbvie Company | 12 | $265 |
| Pfizer | 10 | $220 |
| AbbVie | 5 | $149 |
| Daiichi Sankyo Inc. | 6 | $140 |
| Eisai Inc. | 6 | $130 |
| AstraZeneca(2 entities) | 5 | $114 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $100 |
| Gilead | 4 | $91 |
| Novartis | 4 | $87 |
| Global Blood Therapeutics, Inc. | 4 | $76 |
| Blue Earth Diagnostics | 3 | $72 |
| E.r. Squibb & Sons, L.L.C. | 4 | $71 |
| Incyte Corporation | 3 | $61 |
| Merck | 2 | $52 |
| Myriad Genetic Laboratories, Inc. | 2 | $46 |
| Deciphera Pharmaceuticals Inc. | 2 | $41 |
| Beigene USA, Inc. | 2 | $40 |
| Astellas Pharma US Inc | 2 | $40 |
| Rigel Pharmaceuticals, Inc. | 1 | $31 |
| Pharmaessentia USA Corporation | 1 | $29 |
| Epizyme, Inc. | 1 | $26 |
| Biogen | 1 | $24 |
| Karyopharm Therapeutics Inc. | 1 | $24 |
| Array Biopharma Inc | 1 | $24 |
| Amgen | 1 | $23 |
| Boehringer Ingelheim | 1 | $22 |
| Bristol Myers Squibb | 1 | $22 |
| Sanofi | 1 | $21 |
| Pharmacosmos Therapeutics Inc. | 1 | $21 |
| Exact Sciences | 1 | $20 |
| Sobi, Inc | 1 | $20 |
| Taiho Oncology, Inc. | 1 | $19 |
| Mirati Therapeutics, Inc. | 1 | $19 |
| Novo Nordisk | 1 | $17 |
| Myovant Sciences Inc. | 1 | $17 |
| Mylan Institutional Inc. | 1 | $16 |
| Heron Therapeutics, Inc. | 1 | $13 |
How this compares
$3,279 in reported general payments places this provider in the 80th percentile of 368 adult health providers in Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TukysaTucatinib | 16 | $287,212 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Seagen Inc.Tukysa | $360 | $287,21216 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 368 adult health providers in Virginia.
Other adult health in Leesburg
- Amanda DaytonLeesburg$7K
- Julie LittlejohnLeesburg$3K
- Christine KesslerFort Belvoir$107K
- Denise BruenCharlottesville$45K
- Theresa Harrington StukusFairfax$40K
- Chelsea KoskovichFredericksburg$34K
- Brittany BrownLynchburg$14K
- Colleen DieringVirginia Beach$13K
- Veronica HughesRichmond$12K
- Nicole SellersNorfolk$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.